Global Oral Thin Film Drugs Market Report 2022-2030 Featuring Monosol Rx, Tesa Labtec, Pfizer, Novartis, Wolters Kluwer, Solvay, Allergan, Sumitomo Dainippon Pharma, Intelgenx, Transition Therapeutics

DUBLIN, Feb. 10, 2023 /PRNewswire/ -- The "Oral Thin Film Drugs Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 To 2030" report has been added to  ResearchAndMarkets.com's offering.

This study report represents analysis of each segment from 2020 to 2030 considering 2021 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2030.

The "Oral Thin Film Drugs Market" report provides strategic insights into the overall oral thin film drugs market along with the market size and estimates for the duration 2022 to 2030. The research study covers in-depth analysis of market segments based on product type, and different geographical region.

Thin film drugs have been identified as the alternative approach to the conventional dosage forms. Oral thin films are thin, flexible films of drug delivery that dissolve in the oral mucosa resulting in the rapid onset of action and improved bioavailability for drugs.

The oral thin film are mostly used for the geriatric, pediatric and bedridden patient who are unable to intake the solid form of the drug. Rising demand for efficient drug delivery route and its acceptability in the region would further drive the thin film drug manufacturing market in the future.

In order to help strategic decision makers, the report also includes competitive profiling of the leading players in global oral thin film drugs market, attractive investment proposition and market positioning of key manufacturers sections.

Market size and forecast for these regional and country level markets are presented in this study for the period 2020-2030. Market growth rates for the forecast period 2020-2030 are also included in this report, considering 2021 as the base year.

Along with quantitative information, qualitative information sets and assessment tools are provided in this study for better analysis of the overall market scenario and future prospects. Information such as market inclination insights and drivers, challenges and opportunities assists the readers for understanding the ongoing trends in the global oral thin film drugs market.

Tools such as market positioning of key players and attractive investment proposition provide the readers with insights on the competitive scenario of the global oral thin film drugs market. This report concludes with company profiles section that highlights major information about the key players engaged in global oral thin film drugs market. In-depth competitive environment analysis and historical years (2021) market size data are also provided in the report.

Scientists throughout the pharmaceutical industry have been trying to explore thin films as the novel drug delivery tool. Thin-film drugs have been identified as the alternative approach to the conventional dosage forms. Based on the type of products, the oral thin film drugs market is segmented into sublingual film and fully dissolving buccal film.

The sublingual film held the largest share in the oral thin film drugs market due to the ease of consumption and its effectiveness as it provides rapid dissolution of the drug without the intake of water and rapid onset of action when delivered orally. There has been a good acceptance of oral drugs as it rules out the problem of dysphagia, a common problem due to difficulty in swallowing in the people of all ages and hence it is anticipated to exhibit tremendous growth rate during the forecast period of 2022 to 2030.

The pharmaceutical industry is focusing its interest in shortening drug development timelines and efficient drug delivery platforms. Moreover, there is an increasing demand for efficient drug delivery technique as well as convenience in the transportation of the drug which has fuelled the oral thin film drugs market in the recent past.

In terms of indication, the oral thin film drugs market is segmented as migraine, schizophrenia, Alzheimers disease, eye diseases, nausea & vomiting, opioid dependence and others. Thin film oral drugs make is it easy to swallow drugs without water, especially for pediatric, geriatric and neurodegenerative patients, where conventional drug delivery is difficult. Hence, Alzheimers disease, migraine and opioid dependence would lead the market in the future.

In the base year 2021, North America was observed as the largest regional segment in the oral thin film drugs market. U.S. led the North America oral thin film drugs market, accounting for more than 80% of the market share due to advanced technologies used in the pharmaceutical research and development for the discovery of novel drug delivery technique.

Moreover, rising demand for efficient drug delivery route and its acceptability in the region would further drive the oral thin film drugs market in the future. However, favorable regulation, growing awareness among the masses and launch of novel products would make Asia Pacific the fastest growing geographical region during the forecast period.

Moreover, rising target population in the region, and major contribution of India and China in the pharmaceutical development would further benefit the thin oral thin film drugs market in the region.

Key questions answered in this report

• What are the key micro and macro environmental factors that are impacting the growth of Oral Thin Film Drugs market?
• What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
• Estimated forecast and market projections up to 2030.
• Which segment accounts for the fastest CAGR during the forecast period?
• Which market segment holds a larger market share and why?
• Are low and middle-income economies investing in the Oral Thin Film Drugs market?
• Which is the largest regional market for Oral Thin Film Drugs market?
• What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
• Which are the key trends driving Oral Thin Film Drugs market growth?
• Who are the key competitors and what are their key strategies to enhance their market presence in the Oral Thin Film Drugs market worldwide?

Company Profiles

• Monosol Rx
• Tesa Labtec Gmbh
• Pfizer Inc
• Novartis Ag
• Wolters Kluwer
• Solvay
• Allergan Plc
• Sumitomo Dainippon Pharma Co. Ltd
• Intelgenx Corp
• Transition Therapeutics Inc.

Key Topics Covered:

1. Preface

2. Executive Summary
2.1. Market Snapshot: Global Oral Thin Film Drugs Market
2.2. Global Oral Thin Film Drugs Market, By Product, 2021 (US$ Million)
2.3. Global Oral Thin Film Drugs Market, By Indication, 2021 (US$ Million)
2.4. Global Oral Thin Film Drugs Market, By Geography, 2021 (US$ Million)
2.5. Impact of Covid 19
2.6. Attractive Investment Proposition by Geography, 2021
2.7. Competitive Analysis
2.7.1. Market Positioning of Key Oral Thin Film Drugs Market Vendors
2.7.2. Strategies Adopted by Oral Thin Film Drugs Market Vendors
2.7.3. Key Industry Strategies

3. Oral Thin Film Drugs Market: Business Outlook - Market Dynamics
3.1. Introduction
3.2. Global Oral Thin Film Drugs Market Value, 2020 - 2030, (US$ Million)
3.3. Market Dynamics
3.3.1. Market Drivers
3.3.2. Market Restraints
3.3.3. Key Challenges
3.3.4. Key Opportunities
3.4. Impact Analysis of Drivers and Restraints
3.5. See-Saw Analysis
3.6. Porter's Five Force Model
3.7. PESTEL Analysis

4. Oral Thin Film Drugs Market: By Product, 2020-2030, USD (Million)
4.1. Market Overview
4.2. Growth - Revenue Analysis: 2021 Versus 2030
4.3. Market Segmentation
4.3.1. Sublingual Film
4.3.2. Fully Dissolving Buccal Film

5. Oral Thin Film Drugs Market: By Indication, 2020-2030, USD (Million)
5.1. Market Overview
5.2. Growth - Revenue Analysis: 2021 Versus 2030
5.3. Market Segmentation
5.3.1. Migrainet
5.3.2. Schizophrenia
5.3.3. Alzheimer's Disease
5.3.4. Nausea - Vomiting
5.3.5. Opioid Dependence Tests
5.3.6. Other Indication

For more information about this report visit https://www.researchandmarkets.com/r/616eik-thin-film?w=5

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]
 
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
 
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets